标题
Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major
作者
关键词
Parasitic diseases, Promastigotes, Leishmania donovani, Point mutation, Sand flies, Leishmaniasis, Macrophages, Parasitic life cycles
出版物
PLoS Neglected Tropical Diseases
Volume 9, Issue 7, Pages e0003948
出版商
Public Library of Science (PLoS)
发表日期
2015-08-01
DOI
10.1371/journal.pntd.0003948
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fitness of Leishmania donovani Parasites Resistant to Drug Combinations
- (2015) Raquel García-Hernández et al. PLoS Neglected Tropical Diseases
- Multi-analytical platform metabolomic approach to study miltefosine mechanism of action and resistance in Leishmania
- (2014) Gisele A. B. Canuto et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- In VitroScreening Test Using Leishmania Promastigotes Stably Expressing mCherry Protein
- (2014) Paola Vacchina et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum
- (2014) S. Hendrickx et al. PARASITOLOGY RESEARCH
- LmaPA2G4, a Homolog of Human Ebp1, Is an Essential Gene and Inhibits Cell Proliferation in L. major
- (2014) Brianna Norris-Mullins et al. PLoS Neglected Tropical Diseases
- Untargeted metabolomic analysis of miltefosine action in Leishmania infantum reveals changes to the internal lipid metabolism
- (2013) Isabel M. Vincent et al. International Journal for Parasitology-Drugs and Drug Resistance
- Drug-resistant microorganisms with a higher fitness – can medicines boost pathogens?
- (2012) Manu Vanaerschot et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
- (2012) T. P. C. Dorlo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- Leishmaniasis: Current status of available drugs and new potential drug targets
- (2012) Nisha Singh et al. Asian Pacific Journal of Tropical Medicine
- Impact of Continuous Axenic Cultivation in Leishmania infantum Virulence
- (2012) Diana Moreira et al. PLoS Neglected Tropical Diseases
- Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection Protocol
- (2012) Sarah Hendrickx et al. PLoS Neglected Tropical Diseases
- Multiple Mutations in Heterogeneous Miltefosine-Resistant Leishmania major Population as Determined by Whole Genome Sequencing
- (2012) Adriano C. Coelho et al. PLoS Neglected Tropical Diseases
- Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis
- (2012) Vasundhra Bhandari et al. PLoS Neglected Tropical Diseases
- In vitro interactions between sitamaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani
- (2011) K. Seifert et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes
- (2011) Fernanda de Aquino Marinho et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines
- (2011) M. OUAKAD et al. PARASITOLOGY
- Antimonial Resistance in Leishmania donovani Is Associated with Increased In Vivo Parasite Burden
- (2011) Manu Vanaerschot et al. PLoS One
- Leishmania majorMPK7 Protein Kinase Activity Inhibits Intracellular Growth of the Pathogenic Amastigote Stage
- (2009) Miguel A. Morales et al. EUKARYOTIC CELL
- Fitness costs of resistance to antimalarial drugs
- (2008) Ingrid Felger et al. TRENDS IN PARASITOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started